fbpx

  

Trade the SPY🔎 I No Slowing Down 💪 I Gift OMG 🎁

Good day, 360!

Here are our top investing ideas today. These setups look primed! Be the best prepared trader on the Street!

And a special invitation to join Jeff Williams TONIGHT to see how he’s moneyballing the SPY — if you’re NEW to options trading and want to learn, this is THE place for you! Join here at 8pm EST.

FOCUS LIST🔎

ACON – Up over 80% in pre-market after receiving patent

CGEN – In play after closing up over 173% yesterday 

POL – Up over 90% in pre, after major shareholder issues letter 

SPOTLIGHT💡 

“Jeff, what is your average trade size…it must be HUGE?”

It’s only about one million $3500! 

*Trading is hard, results not guaranteed and should not be expected to be replicated typically.

Almost 6 months into his $10,000 Monthly Mission…

And he’s NOT slowing down!

HOTLIST🔥

ACON – Up over 80% in pre-market after receiving patent 

Aclarion (ACON) is a healthcare technology company that leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. The company develops NOCISCAN Post-Processor suite of software applications.

It was announced yesterday in the after-hours that ACON had been granted U.S Patent #11844601 for “MR SPECTROSCOPY SYSTEM FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS (Severe Low Back Pain)”. 

The stock is trading up over 90% in pre-market after the news.

$0.50 is a prior support area and will be an important level to watch. 

Above it, targets to the upside are $0.55 and then the pre-market high at $0.61. Beyond that, $0.70, $0.80 and $1 come into play.

Below $0.50, there is potential support at $0.45, $0.40, $0.36 and a gap to fill at $0.29.

CGEN – In play after closing up over 173% yesterday 

Compugen (CGEN) is a clinical-stage therapeutic discovery and development company that researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe.

Yesterday the company announced that it had signed an exclusive licence agreement with Gilead Sciences for a novel pre-clinical immunotherapy program in a total deal value of up to $848million. 

Based on yesterday’s close CGEN still had a market cap of less than $185 million according to Finviz.com. Also Stifel maintained its Buy rating on CGEN and raised its price target to $4 for the stock yesterday.

CGEN is up about 4% in pre-market and is one to have on your radar this morning.

The $2 round number should be an important pivot point today.

Above it, targets to the upside are $2.10, $2.20, $2.30 and then yesterday’s high of $2.46. Beyond that, $3 and $3.50 come into play.

Below $2, there is potential support at $1.90, $1.80, $1.61 and a gap to fill at $0.73.

POL – Up over 90% in pre, after major shareholder issues letter 

Polished.com Inc. operates an e-commerce platform for appliances, furniture, and home goods in the United States.

In the after-hours yesterday  a Form PX14A6G was filed by Jerald Hammann, a POL shareholder that urged shareholders concerned about their investment in POL to collaborate to increase the effectiveness of the actions.

The stock is up over 50% this morning in pre-market after the filing.

The $2 to $2.05 area has acted as support so far in the pre-market and will be an important level to watch.

Above it, targets to the upside are $2.20, $2.40 and then the pre-market high at $2.48. Beyond that, $3 and $3.25 come into play.

Below $2, there is potential support at $1.70, $1.60 and then a gap to fill at $1.06.

💥 More GREAT trading resources:

Questions or concerns about our products? Email [email protected] © Copyright 2022, RagingBull

DISCLAIMER To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer

FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.

RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.

RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.

*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.

RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.

WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.

 

Author:

Leave your comment

Skip to content